Short Interest in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Expands By 16.8%

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) was the target of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 89,600 shares, an increase of 16.8% from the October 31st total of 76,700 shares. Approximately 3.9% of the shares of the company are short sold. Based on an average daily volume of 38,000 shares, the short-interest ratio is currently 2.4 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on Cumberland Pharmaceuticals in a research note on Tuesday, November 26th. They issued a “hold” rating on the stock.

Cumberland Pharmaceuticals Stock Performance

Shares of NASDAQ:CPIX traded down $0.05 during trading on Tuesday, hitting $1.25. 118,772 shares of the company were exchanged, compared to its average volume of 28,941. The company has a market cap of $17.55 million, a PE ratio of -1.62 and a beta of 0.30. The stock has a 50 day moving average of $1.22 and a 200 day moving average of $1.36. Cumberland Pharmaceuticals has a 52-week low of $1.04 and a 52-week high of $2.36. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.13 and a quick ratio of 0.99.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.